I’m a 71-yr old female whose platelets have been elevated for 7+ years. They bounced around 400-450 for years, then went up to 450-500 in 2022-2023. A biopsy in Jan 2024 confirmed JAK2 mutation. My platelets moved as high as 550 in mid-2024 but are now down to 470-490.
I have been advised to take hydroxyurea and aspirin. Thus far I have deferred taking the chemo drug for various reasons, (1) the effect on WBC and overall immune functioning (2) my elevated cancer risks due to PMS2 Lynch Syndrome and family history of breast cancer (3) risk of unpleasant side effects.
I feel great right now. I have no symptoms of ET. I get lots of exercise, I eat reasonably well, I'm not overweight, I do not smoke, I don’t have diabetes, no prior history of thrombosis, no known cardiovascular risks. I don’t want to ruin a good thing by taking a toxin.
My hematologist recently said ET and other MPN's cause abnormal (immature) blood cells, which are inflammatory, and which hydroxyurea can impact for the better, even at <600. She sent me some links to be extra convincing (but unfortunately these studies are all over my head).
ashpublications.org/blood/a...
pubmed.ncbi.nlm.nih.gov/214...
pubmed.ncbi.nlm.nih.gov/217...
When I consulted with a different hematology specialist back in October, he thought deferring was a reasonable choice given that my platelet count is already in the 400-600 range w/o treatment.
I know hydroxyurea is inevitable at some point, but I’d prefer to wait until my platelets are over 600. No one can tell me my personalized risk of thrombosis with platelets between 450-600. Any thoughts?